Boston Scientific’s Emerge™ PTCA Balloon Dilatation Catheter Cleared For U.S. Launch



Boston Scientific Launches Emerge™ PTCA Balloon Dilatation Catheter in the U.S. (via PR Newswire)

NATICK, Mass., Sept. 27, 2012 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration clearance for the Emerge™ Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Dilatation Catheter and has begun  marketing the device in the United States…